Tag: iga nephropathy
Renalys Pharma announces first patient dosed in Phase III clinical trial...
Renalys Pharma has announced last week that the first person was dosed in its registrational Phase III clinical trial of sparsentan for the treatment...
Renalys Pharma closes ¥6 billion Series A financing to advance kidney...
Renalys Pharma has recently announced completion of a ¥6 billion Series A financing. The financing was led by Catalys Pacific and SR One, along...
Positive budesonide trial results earn FDA drug application approval
Calliditas Therapeutics has announced that the US Food and Drug Administration (FDA) has accepted a submission for a supplemental New Drug Application (sNDA) for...
UK Kidney Week preview: Rare kidney diseases on the RaDaR
Katie Wong is a clinical research fellow at the University College London Department of Renal Medicine (London, UK). She details some of the research...
World Kidney Day: University of Leicester receives million-pound donation to enhance...
Research by the University of Leicester (Leicester, UK) into chronic kidney disease has received a major boost on World Kidney Day (10 March 2022) following...